Atlassian Corp

Insider sales by Atlassian’s chief revenue officer show disciplined, rule‑based divestment, not a loss of confidence—yet the sharp share decline and negative P/E could still weigh investor sentiment.

Atlassian insider Duffy Brian sells 1,451 shares on June 8 via a 10b5‑1 plan—examining the move’s impact on stock value and investor sentiment in the AI‑growth era.

Gene Liu’s routine sell‑to‑cover trades on Atlassian shares show no hidden sell‑off, but the volume and price range highlight tax‑cover strategy, not a bearish outlook.

Atlassian insider sales reveal a disciplined 10b5‑1 plan and routine profit‑taking, but fundamentals—cloud revenue, AI growth, and earnings—remain strong.

CEO Mike Cannon‑Brookes sells 8,565 Atlassian shares under a 10b‑5 plan, revealing a routine liquidity move amid a 52‑week low but strong AI‑driven growth outlook.

Insider sales spike at Atlassian: CEO Michael Cannon‑Brookes sells 5,200 shares—what this means for investors and stock value in a volatile market.

Insider selling sprees at Atlassian: Farquhar Scott’s 3,500‑share dump amid a steep 70% decline, yet AI‑roadmap and disciplined 10b‑5‑1 plan suggest it’s portfolio management, not panic.

Atlassian insider moves reveal a quiet upside: a CEO grant shows long‑term confidence, while founder sales are routine, yet AI growth keeps the stock attractive for investors.

CEO Michael Cannon‑Brookes sells 13,842 Atlassian shares in a routine 10b‑5‑1 move—no crisis, just liquidity. Learn how this impacts investors and the stock’s outlook.

Atlassian CEO’s 10b5‑1 insider sale: 13,521 shares sold at €133.69 on Jan 27, 2026—steady, rule‑based moves with minimal market impact but key signals for investors.